Cystic fibrosis-related diabetes testing in Roccastrada
Find health labs to test for Cystic fibrosis-related diabetes in Roccastrada and compare all offers by prices and services.
test prediabete e diabete con autoprelievo by innovabiohealth S.r.l.
Test at-Home / Self-testing
Featured
€35.00
€33.25 with our promocode
See Details
Hemoglobin Test by Centro Diagnostico Trasimeno Srl
Via Fratelli Rosselli, 8, 06061 Castiglione del Lago PG, Italia
45.4 km
Hemoglobin Test by Montalto Ckech-up s.r.l.
Strada Statale Castrense Campo Morto, 312, 01014 Montalto di Castro VT, Italia
50.6 km
Unverified
A Diabetes Test costs €50.00
See Details
Hemoglobin Test by Synlab
Piazza della Stazione, 2, 50123 Firenze FI, Italia
52.6 km
Diabetes Test by Casa della Salute
Via San Benedetto, 20, 50066 Reggello FI, Italia
50 km
Hemoglobin Test by Farmacia Giotti Dr.Roberto
Via Nazionale, 96, 52010 Chiusi della Verna AR, Italia
61.2 km
Diabetes Test by Centro analisi cliniche Madonie
Via Antonio Gramsci, 39, 50019 Sesto Fiorentino FI, Italia
56.7 km
Diabetes Test by Crabion S.R.L.
Via Amilcare Ponchielli, 8, 06073 Corciano PG, Italia
57.1 km
Unverified
A Diabetes Test costs €49.00
See Details
Diabetes Test by PROTOS Centro Diagnostico
Via del Discobolo, 14, 06132 Perugia PG, Italia
62 km
Unverified
A Diabetes Test costs €30.00
See Details
Hemoglobin Test by Farmacia Etrusca
Via Pistoiese, 174, 59100 Prato PO, Italia
60.2 km
Hemoglobin Test by Farmacia Picconi
Via Provinciale Montalbano, 371, 51034 Serravalle Pistoiese PT, Italia
64 km
Cystic fibrosis-related diabetes - symptoms and how to test
Diabetes mellitus is a common disease; however, cystic fibrosis can cause a unique type of disease called cystic fibrosis-related diabetes (CFRD). This type of diabetes mellitus is different from both type 1, and type 2 diabetes yet has specific characteristics. The primary reason is insulin insufficiency due to islet cell death. Adults and adolescents with cystic fibrosis often develop diabetes because of their condition. Moreover, a third of CF patients aged 16 and up are receiving therapy for CFRD, according to 2018 data from the UK CF Registry. Among children aged 10 to 15, just 11% are receiving medication. There is evidence that early treatment of diabetes improves prognosis, and the fact that diabetes and poor glucose tolerance are both associated with worse health outcomes in people with CF emphasises the necessity of an early diagnosis.
